Helvetica Chimica Acta · 2009 · 29 citations · 17 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyMolecular PharmacologyStructural BiologyLigand BindingReceptor PharmacologyReceptor-ligand InteractionsBioactivityG Protein-coupled Receptor Structure-function RelationshipsG-protein-coupled ReceptorsSomatostatin AnaloguesSomatostatin Pharmacology
Abstract The previously reported ( Helv. Chim. Acta 2008 , 91 , 2035) derivatives of octreotide ( 1 ) with a (CF 3 )‐Trp substitution, i.e. , 3 , and with open‐chain structures, i.e. , 2, 4 , and 5 , have been tested for their affinities to hsst 1–5 receptors and subjected to a detailed NMR analysis. Their affinities vary from 15 n M to 5 μ M , as compared to 0.6 n M to 0.8 μ M for octreotide itself ( Table 1 ). This decreased bioactivity may have had to be expected for the open‐chain compounds 4 and 5 ; possible reasons for this decrease in the case of CF 3 derivative of octreotide, 3 , are discussed. NMR Analysis ( Tables 2 and 3 ) provides evidence for increased dynamics of all new derivatives 2 – 5 . The dynamics of the octreotide molecule 1 was analyzed by (natural‐abundance) longitudinal 13 C‐T 1 ‐relaxation time measurements ( Table 4 ), from which the conclusion is drawn that the backbone of the macrocycle is rather rigid on the time scale of this method.
17
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
W. Bauer, U. Briner, W. Doepfner et al. · Life Sciences · 1982 · 1.3K citations
Dieter Seebàch · Angewandte Chemie International Edition in English · 1990 · 577 citations
Classification and nomenclature of somatostatin receptors
Daniël Hoyer, G I Bell, Michael Berelowitz et al. · Trends in Pharmacological Sciences · 1995 · 572 citations · Full text
Stefania Capone, Iris Kieltsch, Oliver Flögel et al. · Helvetica Chimica Acta · 2008 · 92 citations